Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.70 |
| ▸ | ADORA2A | P29274 | 4/20 | 0.62 |
| ▸ | ADORA1 | P30542 | 4/20 | 0.62 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.62 |
| ▸ | ADORA2B | P29275 | 3/20 | 0.62 |
| ▸ | POLB | P06746 | 1/20 | 0.62 |
| ▸ | RAB9A | P51151 | 3/20 | 0.61 |
| ▸ | NPC1 | O15118 | 2/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 7/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.54 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.50 |
| ▸ | RELA | Q04206 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17720978 | 1.00 | L3MBTL1 (0.70) | L3MBTL1ADORA2AADORA1ADORA3ADORA2B | |
| SCHEMBL371042 | 0.97 | L3MBTL1 (0.74) | L3MBTL1ADORA2AADORA1ADORA3ADORA2B | |
| SCHEMBL17995341 | 0.94 | L3MBTL1 (0.64) | L3MBTL1ADORA2AADORA1ADORA3ADORA2B | |
| SCHEMBL17995340 | 0.94 | L3MBTL1 (0.64) | L3MBTL1ADORA2AADORA1ADORA3ADORA2B | |
| SCHEMBL18680544 | 0.94 | L3MBTL1 (0.64) | L3MBTL1ADORA2AADORA1ADORA3ADORA2B | |
| SCHEMBL17720953 | 0.94 | L3MBTL1 (0.64) | L3MBTL1ADORA2AADORA1ADORA3ADORA2B | |
| SCHEMBL17995338 | 0.94 | L3MBTL1 (0.64) | L3MBTL1ADORA2AADORA1ADORA3ADORA2B | |
| SCHEMBL6112014 | 0.93 | L3MBTL1 (0.70) | L3MBTL1ADORA2AADORA1ADORA3ADORA2B | |
| SCHEMBL18212420 | 0.93 | L3MBTL1 (0.70) | L3MBTL1ADORA2AADORA1ADORA3ADORA2B | |
| SCHEMBL23608941 | 0.90 | L3MBTL1 (0.67) | L3MBTL1ADORA2AADORA1ADORA3ADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006076092-A9 | PHOSPHORESCENT OLEDS WITH EXCITON BLOCKING LAYER | EASTMAN KODAK CO (US) | 2007-06-28 | — | — | WO | claimed |
| US-20060134461-A1 | Organometallic materials and electroluminescent devices | EASTMAN KODAK COMPANY | 2006-06-22 | — | — | US | claimed |
| US-20060134460-A1 | Phosphorescent oleds with exciton blocking layer | GLOBAL OLED TECHNOLOGY LLC | 2006-06-22 | — | — | US | claimed |
| US-11818948-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-14 | — | — | US | disclosed |
| US-11818948-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-14 | — | — | US | disclosed |
| US-11744151-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-08-29 | — | — | US | disclosed |
| US-11744151-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-08-29 | — | — | US | disclosed |
| US-20210249608-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORP (US) | 2021-08-12 | — | — | US | disclosed |
| US-11024808-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2021-06-01 | — | — | US | disclosed |
| EP-2984079-B1 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES | POWER OLEDS LTD (GB) | 2020-07-01 | — | — | EP | disclosed |
| US-10439147-B2 | Heterocyclic compounds and their use in electro-optical or opto-electronic devices | POWER OLEDS LIMITED (GB) | 2019-10-08 | — | — | US | disclosed |
| US-20070134514-A1 | Electroluminescent host material | EASTMAN KODAK COMPANY | 2007-06-14 | — | — | US | disclosed |
| WO-2007064479-A1 | ELECTROLUMINESCENT DEVICE WITH QUINAZOLINE COMPLEX EMITTER | EASTMAN KODAK COMPANY (US) | 2007-06-07 | — | — | WO | disclosed |
| US-20070122655-A1 | Electroluminescent device with quinazoline complex emitter | EASTMAN KODAK COMPANY | 2007-05-31 | — | — | US | disclosed |
| US-20070111026-A1 | Oled devices with dinuclear copper compounds | GLOBAL OLED TECHNOLOGY LLC | 2007-05-17 | — | — | US | disclosed |
| US-20060246315-A1 | Phosphorescent oled with mixed electron transport materials | EASTMAN KODAK COMPANY | 2006-11-02 | — | — | US | disclosed |
| US-20060228579-A1 | Organometallic materials and electroluminescent devices | EASTMAN KODAK COMPANY | 2006-10-12 | — | — | US | disclosed |
| WO-2006076092-A1 | PHOSPHORESCENT OLEDS WITH EXCITON BLOCKING LAYER | EASTMAN KODAK COMPANY (US) | 2006-07-20 | — | — | WO | disclosed |
| US-20060134461-A1 | Organometallic materials and electroluminescent devices | EASTMAN KODAK COMPANY | 2006-06-22 | — | — | US | disclosed |
| US-20060134460-A1 | Phosphorescent oleds with exciton blocking layer | GLOBAL OLED TECHNOLOGY LLC | 2006-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11744151-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, JUND | L3MBTL1 2912/4885ADORA2A 1166/4885ADORA1 2424/4885 |
| US-11024808-B2 | Organic electroluminescent materials and devices | SLCO4C1, SLC29A1, SLC29A2 | L3MBTL1 823/4885ADORA2A 691/4885ADORA1 1351/4885 |
| US-10439147-B2 | Heterocyclic compounds and their use in electro-optical or opto-electronic devices | NAT1, SLCO2A1, SLCO2B1 | L3MBTL1 899/4885ADORA2A 454/4885ADORA1 132/4885 |
| US-11818948-B2 | Organic electroluminescent materials and devices | SLCO4C1, SLC29A1, SLC29A2 | L3MBTL1 823/4885ADORA2A 691/4885ADORA1 1351/4885 |
| US-20210249608-A1 | Organic Electroluminescent Materials and Devices | SLCO4C1, SLC29A1, SLC29A2 | L3MBTL1 823/4885ADORA2A 691/4885ADORA1 1351/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.